All News

Is exercise safe in PsO/PsA? Ab0497 #ACR23 US of entheses before & after 60 min of badminton 🏸 7 PsA pts, 9 PsO pts, 196 US scans acquired. No signif change in VAS pain/tender entheses 4 pts w grade 1 doppler at 6 entheses, butnon-tender 1 pt w active PsA had worsening @RheumNow https://t.co/nsi9b6px0X
Eric Dein  ( View Tweet)
Translational implication/application of the #APOL1 story : Risk stratification, novel treatments, impact of tissue susceptibility to damage #ACR23 @RheumNow #DuboisLecture #SLE @ashira_md https://t.co/k23vFjeDeG
TheDaoIndex KDAO2011 ( View Tweet)
Ab#498 Does DMARD for PsO and PsA decrease MACE? #ACR23 @RheumNow Retrospective database Israeli study. PsO, PsA on MTX or bDMARD: lower MACE compared to health matched controled (HR 0.45-0.68, p<0.001) Pts on topical Rx had marginally Increased MACE (HR 1.14, p <0.001) https://t.co/0uRgjzYbFp
Eric Dein  ( View Tweet)
BKZ tx resulted in sustained improvements in pt‑reported pain and fatigue from Wk 16 - 52 in bDMARD-naïve and TNFi-IR pts w/ active PsA, w/ clinically meaningful improvements observed in >50% of pts in BE-OPTIMAL & BE-COMPLETE #ACR23 Abs 0527 https://t.co/AQKYUubKLl @rheumnow https://t.co/WsXlhENzL1
Dr. Rachel Tate  ( View Tweet)
Abs#0501 @RheumNow #ACR23 Uveitis in SpA, from Greece AxSpA: 11.7% Uveitis. RF: HLA-B27 (OR 4.15), periperhal arthritis (OR 3.05) PsA: 2.7% Uveitis. Ass w/ SpA FHx, Axial dis at dx, disease duration Permanent vision loss in 16% AxSpA, 30% PsA pts, all with recurrent uveitis

Eric Dein  ( View Tweet)

EISER study: Undiagnosed IBD in SpA Abs#0495 #ACR23 @RheumNow 559 pts, 47% PsA/53% SpA (80% r-AxSpA) Higher mean fecal calprotectin in r-AxSpA (395 vs 305 nrAxSpA/PsA) 14.6% IBD symptoms, 23 patients (4.4% were dx w IBD) Fecal calprotectin & history can uncover IBD #ACRBest

Eric Dein  ( View Tweet)

#ACR23 Please find my preview article on selected #SLE abstracts to be presented at year’s conference - towards Glucocorticoid-Free zone in lupus @RheumNow https://t.co/1kM7LWc64V https://t.co/WK9X7UpsNi
Md Yuzaiful Md Yusof  ( View Tweet)
High hs-CRP predicts PsO -> PsA? Abs#0484 #ACR23 @RheumNow 589 PsO pts wo PsA, followed mean 7.5 years 57 pts developed PsA (1.2 events/yr) Higher levels of b/l hs-CRP seen w: arthrlalgia, obesity, females Higher hs-CRP ass. w/ PsA - p=0.002, but HR only 1.03 (CI 1.01-1.05)

Eric Dein  ( View Tweet)

Long term results of the MAINRITSAN study (Maintenance Remission w/ RTX in Systemic AAV) showed fixed-schedule RTX superior to AZA in preventing major relapses at 84mos (HR 0.38), but tailored-RTX assoc w/ incr risk of major relapse (HR 2.92) https://t.co/vucBYeM1P5 https://t.co/YqdqZWFhfd

Links:

Dr. John Cush RheumNow ( View Tweet)
In young patients who have a spinal MRI, lesions are reported in most patients, and similar in males:females. SIJ MRI findings are reported in one out of three patients, being more frequently in males @DiegoBenavent Abst #160 #ACR23 @RheumNow https://t.co/aF9WnP7jpY https://t.co/E9UuZ0sWZm
Dr. Antoni Chan  ( View Tweet)
#Benefits of #hudroxychloroquine - reduced lipids, clots, CV events, infection AND now improved #fatty #liver #NAFLD….@RheumNow #ACR23 @ACRheum https://t.co/Y43JETY6F3

Janet Pope  ( View Tweet)

Sarilumab for relapsing of PMR. Any thing to to taper off prednisone quickly. #ACR23 , year in review. Lost of good studies and smart discussions @RheumNow at Make rheum for PMR month. https://t.co/VyRP8ls3OC
Nouf Al hemmadi  ( View Tweet)
Thank you @synovialjoints @RheumNow for highlighting our work #ACR23 #ACRambassador @ACRheum @ArLARheumatolog #ARCH_ArLAR https://t.co/rphaODphD1

Nelly ZIADE 🍀 Nellziade ( View Tweet)

If successful you may need how to pronounce these emerging therapeutics in #inflammatory #arthritis @RheumNow #ACR23 @ACRheum https://t.co/aOogwQCsCM

Janet Pope  ( View Tweet)

One for you, one for me! So many pasalubong char @RHEUMarampa @RheumNow #acr23 #ACRambassador https://t.co/v0mZ9vbadx

Links:

Lisa 🐳🗺🧭 rheumarhyme ( View Tweet)
Cellular based biology explanation of sex bias in ARDs 👀 Data from AMP w/ sc-RNA seq from synovial tissue shows: Enriched inflammatory pathways in females synovial macrophages clusters vs. males Basis for gender specific treatment strategies? @RheumNow ABST0724 #ACR23 https://t.co/1p8PDIRNoI
Aurelie Najm  ( View Tweet)
Is there a difference in secukinumab vs. adalimumab biosimilar on radiographic progression in a subgroup of axSpA pts with syndesmophytes or CRP levels? Radiographic progression equally low in both drugs NO difference in syndesmophytes or CRP @RheumNow #ACR23 Abs#0522 https://t.co/1TBKAxuKPE
Robert B Chao, MD  ( View Tweet)
In their study, Dr Deng et al identified TRAF5 as susceptible gene for SLE-PAH ✳️TRAF5 deficiency activates BMP/TGFB signaling w/⬆️PAEC apoptosis ✳️TRAF5 overexpression attenuated PAH sxs in mice TRAF5 as potential BM for dx/novel tx target in SLE-PAH? #ACR23 ABST0723 @RheumNow https://t.co/WT9vQo8y8s
sheila  ( View Tweet)
Important plenary re:reduced vs standard GC for AAV... IRL PEXIVAS & recent guidelines supported low dose taper Real world data w/severe dx? Increased risk of death & ESKD for REDUCED pts Need full data but yikes... @RheumNow #ACR23 #ACRBest https://t.co/3S23O9d1ok
Mike Putman EBRheum ( View Tweet)
Abst#0725 #ACR23 @RheumNow PEXIVAS Real life data! GPA & MPA pts - Retrosp observ study ⭐️Reduced-dose GC regimen ass w/ INCREASED risk of death, ESKD, progression Greatest risk: pt w Cr levels >300 umol/L, RTX induction Rx ⚠️Caution w/ reduced GC, RTX, severe kidney dis #ACRBest https://t.co/7qI5c1ZiqO
Eric Dein  ( View Tweet)
×